NIH-funded research R15 grant

PFAS chemicals may boost mosquito problems and disease risk

Official title: Determining the effect of per- and polyfluoroalkyl substances (PFAS) on mosquito fitness and arbovirus transmission potential

Funded at Kennesaw State University · NIH-11444964 · Data updated 2026-11-12

This grant tests how common water pollutants called PFAS affect mosquitoes and their ability to spread diseases.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionKennesaw State University
NIH-funded
Lab location1 site (Kennesaw, United States)
Project startSeptember 1, 2026
Project endJuly 31, 2029
Funding year2026
Award (this year)$517,956
NIH project number1R15AI194160-01A1
Project IDNIH-11444964 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are communities in PFAS-contaminated environments and researchers studying vector-borne diseases.

Less likely to help

People not exposed to PFAS or not concerned with mosquito-borne diseases may not directly benefit.

What this research studies

The researchers will study real-world PFAS exposure in several mosquito species to see how it changes their survival and ability to transmit viruses. They use newly developed mosquito models to mimic conditions mosquitoes encounter as larvae and adults. The goal is to understand whether PFAS exposure could make mosquitoes more dangerous to people living in areas with PFAS pollution. The project is funded to advance knowledge that could inform public health and environmental cleanup decisions.

Why it matters

Potential benefit: If PFAS exposure alters mosquito transmission, this work could guide strategies to reduce disease risk in polluted areas.

How similar studies have gone: Previous work suggests environmental contaminants can affect insect biology, but direct links to arbovirus transmission are being explored here.

Where this research is happening

  • Kennesaw State University
    Kennesaw, United States
    Active

Researchers

  • Principal investigator: Haddow, Andrew — Kennesaw State University
  • Study coordinator: Haddow, Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.